Heartview Foundation Cando

Type of Care

Substance use treatment Detoxification

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient Residential/24-hour residential Outpatient day treatment or partial hospitalization Intensive outpatient treatment Outpatient methadone/buprenorphine or naltrexone treatment Regular outpatient treatment Residential detoxification Long-term residential Short-term residential

Opioid Medications used in Treatment

Buprenorphine used in Treatment Naltrexone used in Treatment

External Opioid Medications Source

In-network prescribing entity Other contracted prescribing entity No formal relationship with prescribing entity

Type of Alcohol Use Disorder Treatment

Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere This facility administers/prescribes medication for alcohol use disorder

External Source of Medications Used for Alcohol Use Disorder Treatment

In-network prescribing entity Other contracted prescribing entity No formal relationship with prescribing entity

Type of Opioid Treatment

Buprenorphine maintenance Prescribes buprenorphine Prescribes naltrexone Relapse prevention with naltrexone Accepts clients using MAT but prescribed elsewhere Lofexidine or Clonidine detoxification Maintenance service with medically supervised withdrawal after stabilization

Pharmacotherapies

Acamprosate (Campral®) Disulfiram Buprenorphine with naloxone Buprenorphine without naloxone Buprenorphine (extended-release, injectable) Naltrexone (oral) Naltrexone (extended-release, injectable) Clonidine Medication for mental disorders Nicotine replacement Non-nicotine smoking/tobacco cessation

Treatment Approaches

Brief intervention Cognitive behavioral therapy Contingency management/motivational incentives Motivational interviewing Relapse prevention Substance use disorder counseling Trauma-related counseling Telemedicine/telehealth therapy 12-step facilitation

Facility Operation (e.g., Private, Public)

Private non-profit organization

License/Certification/Accreditation

State Substance use treatment agency The Joint Commission

Payment/Insurance/Funding Accepted

Federal, or any government funding for substance use treatment programs IHS/Tribal/Urban (ITU) funds Medicare Medicaid Federal military insurance (e.g., TRICARE) Private health insurance Cash or self-payment State-financed health insurance plan other than Medicaid

Special Programs/Groups Offered

Clients with co-occurring mental and substance use disorders

Assessment/Pre-treatment

Comprehensive mental health assessment Comprehensive substance use assessment Complete medical history/physical exam Screening for tobacco use Screening for substance use Screening for mental disorders

Testing

Breathalyzer or blood alcohol testing Drug or alcohol urine screening

Transitional Services

Aftercare/continuing care Discharge Planning Naloxone and overdose education Outcome follow-up after discharge

Recovery Support Services

Self-help groups Housing services Assistance with obtaining social services

Other Services

Treatment for other addiction disorder

Detoxification (medical withdrawal) Services

Alcohol Detoxification Benzodiazepines Detoxification Cocaine Detoxification Methamphetamines detoxification Opioids detoxification Medication routinely used during detoxification

Education and Counseling Services

HIV or AIDS education, counseling, or support Hepatitis education, counseling, or support Health education services other than HIV/AIDS or hepatitis Substance use disorder education Smoking/vaping/tobacco cessation counseling Individual counseling Group counseling Family counseling

Facility Smoking Policy

Smoking permitted in designated area

Age Groups Accepted

Children/Adolescents

Sex Accepted

Female Male

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Case management service Mental health services Social skills development Transportation assistance Integrated primary care services Suicide prevention services